CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows From Operating Activities:
Net income	$ 121,555	$ 101,378
Reconciliation to net cash provided by operating activities:
Loss (gain) on disposal of assets	110	474
Impairment of long-lived assets		2,700
Gain on interest rate swaps and foreign currency transactions, net	1,496	(1,019)
Depreciation of property, plant, and equipment	20,992	18,559
Amortization of product rights, trademarks, and patents	18,539	6,651
Operating lease right-of-use asset amortization	3,010	2,778
Amortization of discounts, premium, and debt issuance costs	5,308	8,486
Equity in losses of unconsolidated affiliate	573	1,476
Share-Based Payment Arrangement, Noncash Expense	18,736	15,620
Changes in operating assets and liabilities:
Accounts receivable, net	(24,577)	(30,175)
Inventories	(24,329)	(6,537)
Prepaid expenses and other assets	(10,489)	105
Income tax refunds, deposits, and payable, net	(5,147)	25,185
Operating lease liabilities	(2,866)	(2,667)
Accounts payable and accrued liabilities	61,451	16,625
Net cash provided by operating activities	184,362	159,639
Cash Flows From Investing Activities:
BAQSIMI acquisition	(129,000)	(506,406)
Purchases and construction of property, plant, and equipment	(28,630)	(28,724)
Purchase of investments	(47,507)	(52,802)
Maturity of investments	118,538	38,801
Deposits and other assets	2,653	(3,064)
Net cash provided by (used in) investing activities	(89,252)	(546,067)
Cash Flows From Financing Activities:
Proceeds from equity plans, net of withholding tax payments		7,414
Proceeds from equity plans, net of withholding tax payments	(8,234)
Purchase of treasury stock	(43,456)	(58,144)
Debt issuance costs	(838)	(24,589)
Proceeds from Lines of Credit	13,565
Proceeds from Issuance of Long-Term Debt		845,000
Principal payments on long-term debt	(8,148)	(268,506)
Net cash used in financing activities	(47,111)	501,176
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(179)	(44)
Net increase in cash, cash equivalents, and restricted cash	47,820	114,704
Cash, cash equivalents, and restricted cash at beginning of period	144,531	156,333
Cash, cash equivalents, and restricted cash at end of period	192,351	271,037
Noncash Investing and Financing Activities:
Deferred payment for BAQSIMI acquisition		121,699
Capital expenditures included in accounts payable	5,120	4,496
Operating lease right-of-use assets in exchange for operating lease liabilities	2,386	9,890
Supplemental Disclosures of Cash Flow Information:
Interest Paid, Excluding Capitalized Interest, Operating Activities	22,389	12,098
Income Taxes Paid	$ 29,000	$ 2,136